LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
1-Year Return
25.93%
This Quarter Return
-6.61%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.27B
AUM Growth
-$291M
(-19%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-10.05%
Top 10 Holdings %
Top 10 Hldgs %
24.84%
Holding
415
New
40
Increased
54
Reduced
57
Closed
258
Top Buys
| 1 |
CVS Health
CVS
|
$33M |
| 2 |
Incyte
INCY
|
$26.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
$24.7M |
| 4 |
Halozyme
HALO
|
$24.5M |
| 5 |
Equity Lifestyle Properties
ELS
|
$22.9M |
Top Sells
| 1 |
Pultegroup
PHM
|
$28.6M |
| 2 |
Biogen
BIIB
|
$24.6M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$24.1M |
| 4 |
Abbott
ABT
|
$15.5M |
| 5 |
Pool Corp
POOL
|
$14.2M |
Sector Composition
| 1 | Healthcare | 56.62% |
| 2 | Financials | 13.8% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Technology | 6.24% |
| 5 | Energy | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Keysight
KEYS
$28.6B
| $20.7M | 1.62% |
130,737
+7,138
| +6% | +$1.13M |
|
27
BioNTech
BNTX
$24.9B
| $20.4M | 1.6% |
+119,311
| New | +$20.4M |
|
28
Baxter International
BAX
$12.1B
| $20.3M | 1.59% |
261,255
+257,223
| +6,380% | +$19.9M |
|
29
iRhythm Technologies
IRTC
$5.86B
| $20.2M | 1.59% |
128,518
-32,825
| -20% | -$5.17M |
|
30
Apple
AAPL
$3.53T
| $19.2M | 1.51% |
109,961
-11,229
| -9% | -$1.96M |
|
|
MDRX
31
DELISTED
Veradigm Inc. Common Stock
MDRX
| $19.1M | 1.5% |
848,645
+57,484
| +7% | +$1.29M |
|
|
32
Abbott
ABT
$231B
| $18.6M | 1.46% |
157,492
-131,162
| -45% | -$15.5M |
|
33
Neurocrine Biosciences
NBIX
$13.7B
| $17.9M | 1.4% |
190,568
-72,097
| -27% | -$6.76M |
|
|
RCM
34
DELISTED
R1 RCM Inc. Common Stock
RCM
| $17.6M | 1.38% |
659,521
+81,723
| +14% | +$2.19M |
|
35
DexCom
DXCM
$31.8B
| $16M | 1.25% |
125,056
+123,248
| +6,817% | +$15.8M |
|
36
Microsoft
MSFT
$3.77T
| $15.5M | 1.21% |
50,133
-1,422
| -3% | -$438K |
|
37
Alnylam Pharmaceuticals
ALNY
$59.4B
| $13.6M | 1.06% |
+83,038
| New | +$13.6M |
|
38
Manulife Financial
MFC
$52.3B
| $12.9M | 1.01% |
+604,270
| New | +$12.9M |
|
39
Chemed
CHE
$6.71B
| $12.7M | 0.99% |
25,000
-25,000
| -50% | -$12.7M |
|
40
Virtus Investment Partners
VRTS
$1.31B
| $12M | 0.94% |
50,000
+10,000
| +25% | +$2.4M |
|
41
CRISPR Therapeutics
CRSP
$4.81B
| $12M | 0.94% |
190,685
+12,916
| +7% | +$811K |
|
42
Apellis Pharmaceuticals
APLS
$3.54B
| $11.2M | 0.88% |
221,251
-202,425
| -48% | -$10.3M |
|
|
AMED
43
DELISTED
Amedisys
AMED
| $11.2M | 0.88% |
+65,000
| New | +$11.2M |
|
|
IMGN
44
DELISTED
Immunogen Inc
IMGN
| $10.8M | 0.85% |
2,275,409
-1,168,115
| -34% | -$5.56M |
|
45
Twist Bioscience
TWST
$1.53B
| $10.6M | 0.83% |
214,701
+14,543
| +7% | +$718K |
|
|
SWAV
46
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $10.1M | 0.79% |
+48,739
| New | +$10.1M |
|
|
SGFY
47
DELISTED
Signify Health, Inc.
SGFY
| $9.57M | 0.75% |
527,393
+198,048
| +60% | +$3.59M |
|
48
Teladoc Health
TDOC
$1.36B
| $9.33M | 0.73% |
129,318
-75,221
| -37% | -$5.43M |
|
49
Exact Sciences
EXAS
$9.96B
| $8.55M | 0.67% |
122,209
-55,939
| -31% | -$3.91M |
|
50
United Therapeutics
UTHR
$17.2B
| $8.45M | 0.66% |
+47,079
| New | +$8.45M |
|